skip to primary navigationskip to content

Therapies Workshop

We are all keen to know when and how new stem cell therapies will reach patients. At the SCI we believe it is important to involve patients in discussions about the best ways to achieve and regulate the delivery of advanced therapies.

 

In partnership with UK charity Genetic Alliance, we invited a group of representatives from patient charities and the biopharmaceutical sector to  discuss  the development of advanced stem cell therapies. Prof. Robin Franklin gave an overview of the potential of ongoing research as well as the challenges of bringing therapies to clinic.   

 

img 20151110 160108488

 

Visitors then met with Cora Olpe, Dan Howard, Simón Méndez-Ferrer & Thomas Moreau, who are conducting pioneering research in the field of haematology. They had a chance to look at a fascinating new way to make and mass produce platelets.

 

img 20151110 153647972

RSS Feed Latest news

Cancer treatment: study finds targeting nearby ‘normal’ cells could improve survival rates

Jan 16, 2020

Cancer of the immune system, called lymphoma or leukaemia, generally affects the entire body’s bone marrow and lymph nodes. Because these types of cancers are so widespread, surgery isn’t useful, so patients are usually treated with chemotherapy. Although these treatments have become significantly better in the past ten years, lymphoma and chronic leukaemia often come back months or years after treatment.

Single-cell analysis of the earliest cell fate decisions in development

Dec 11, 2019

Researchers at the Babraham Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), CRUK Cambridge Institute and the Wellcome – MRC Cambridge Stem Cell Institute have provided the first single-cell epigenomic analysis of gastrulation, a crucial process in early embryo development. The researchers analysed over 1,000 cells from mouse embryos to understand the epigenetic priming events preceding gastrulation and the cell fate decisions these establish. The findings, published on Wednesday 11th December in Nature, uncover fundamental knowledge about the processes that programme cell fate in the early embryo to generate all the organs and tissues of the body.

Affiliate group leader Florian Merkle named Robertson Stem Cell Investigator

Oct 23, 2019

The New York Stem Cell Foundation (NYSCF) announced the 2019 class of NYSCF – Robertson Investigators, welcoming six of the most talented stem cell researchers and neuroscientists into the NYSCF Investigator Program.

First cell map of developing human liver reveals how blood and immune system develop

Oct 09, 2019

In a world first, scientists have created the human developmental liver cell atlas that provides crucial insights into how the blood and immune systems develop in the foetus. It maps changes in the cellular landscape of the developing liver between the first and second trimesters of pregnancy, including how stem cells from the liver seed other tissues to support the high demand for oxygen needed for growth.

Diabetes drug reverses cell ageing and could stop multiple sclerosis

Oct 08, 2019

New research published in Cell Stem Cell suggests a common diabetes drug could hold the key to stopping disease progression in multiple sclerosis (MS). The new finding offers hope to people living with advanced forms of the condition, who currently have no treatment and often see disability as inevitable.

View all news

The Cambridge Stem Cell Institute is a world-leading centre for stem cell research.

Our mission: to transform human health through a deep understanding of stem cell biology.

 

Sign up to our newsletter to stay up-to-date with news and events from the Cambridge stem cell community.

Upcoming events

International Seminar - Francis Stewart (For scientists)

Feb 05, 2020

Jeffrey Cheah Biomedical Centre

Cambridge Science Festival - Open Science (For the public)

Mar 22, 2020

Jeffrey Cheah Biomedical Centre

Upcoming events